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Introduction: Matrix metalloproteinase-3 (MMP-3) is well known to mediate neuroinflammatory 
processes by activating microglia, disrupting blood-CNS barriers and supporting neutrophil influx into 
the brain. Also the posterior part of the eye, more specifically the retina, the retinal pigment 
epithelium (RPE) and the blood-retinal barrier (BRB), is affected upon neuroinflammation, but a role 
for MMP-3 during ocular inflammation remains elusive.  
Materials and methods: To investigate whether MMP-3 contributes to acute inflammation in the 
eye, the endotoxin-induced uveitis (EIU) model was applied in mice via intraperitoneal administration 
of lipopolysaccharide (LPS) from Salmonella enterica, using wild-type and MMP-3 deficient (MMP-3-/-
) mice and the semi-specific MMP-3 inhibitor NNGH. The spatiotemporal expression pattern of MMP-
3 during EIU was first evaluated using quantitative PCR (qPCR), Western blotting (WB) and 
immunohistochemistry. Optical coherence tomography (OCT) and the optokinetic tracking response 
were applied to study respectively general retinal morphology and visual acuity of healthy MMP-3-/- 
mice. Leukostasis and leukocyte infiltration were studied via respectively perfusion labelling with 
FITC-conjugated Concanavalin A lectin and OCT. qRT-PCR, a multiplex cytokine bead assay and WB 
were applied to investigate the expression level of inflammatory-associated molecules. 
Results: Healthy MMP-3-/- mice did not show an aberrant retinal morphology or visual acuity. 
Systemic administration of LPS induced MMP-3 mRNA and protein expression in the posterior part of 
the eye, predominantly in the RPE. MMP-3 deficiency or knockdown attenuated the hypothermic 
response after endotoxemia, suppressed leukocyte adhesion to the retinal vasculature and leukocyte 
infiltration into the vitreous cavity in mice subjected to EIU. Moreover, mRNA levels of intercellular 
adhesion molecule 1 (Icam1), interleukin 6 (Il6) and cytokine-inducible nitrogen oxide synthase 
(Nos2), which are key molecules involved in EIU, were clearly reduced in MMP-3-/- retinal and RPE 
samples. In addition, loss of MMP-3 repressed the protein levels of the chemokines monocyte 
chemoattractant protein (MCP)-1 and (C-X-C motif) ligand 1 (CXCL1).  
Conclusion: These findings suggest an important contribution of MMP-3 to the inflammatory 
processes during EIU, and its potential use as a therapeutic drug target in reducing ocular 
inflammation. 
 
